95 results
Page 4 of 5
6-K
1l20qf dqmzjxfpb
9 Dec 20
Report of Foreign Private Issuer
3:37pm
6-K
EX-99.2
myhlxyft271i3 4h
9 Dec 20
Report of Foreign Private Issuer
3:37pm
6-K
EX-99.1
giitql
9 Dec 20
Report of Foreign Private Issuer
3:37pm
6-K
EX-99.1
kwo fgettl7me
8 Dec 20
Gamida Cell Presents Updated, Expanded Results from Phase 1 Study of Natural Killer Cell Therapy GDA-201 at ASH Annual Meeting and Exposition
3:19pm
6-K
EX-99.1
7zrstcucg5m m02vo1zr
10 Nov 20
Gamida Cell Reports Third Quarter 2020 Financial Results and Provides Company Update
8:23am
6-K
EX-99.1
ye5 kpnd1f21k95
5 Nov 20
Gamida Cell Announces Data to Be Presented at 62nd ASH Annual Virtual Meeting
10:36am
6-K
EX-99.1
1eq9k c9a
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.2
n7q6kpep10m ze5a9
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.1
t65ra2iezfgqgy5b
21 May 20
Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update
8:40am
424B5
b8ig sq41v
20 May 20
Prospectus supplement for primary offering
4:08pm
424B5
wdenlys3z1r dm
18 May 20
Prospectus supplement for primary offering
4:11pm
6-K
EX-99.1
ebtjlywaz yvll8rzvs
25 Feb 20
Gamida Cell Reports Full Year 2019 Financial Results and Provides Company Update
5:08pm
6-K
ojbew76n48c
9 Dec 19
Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting
3:30pm
6-K
EX-99.1
z6bhq4
9 Dec 19
Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting
3:30pm
F-3
sjmk3fcemh0pciuorc
14 Nov 19
Shelf registration (foreign)
5:11pm
6-K
EX-99.1
9v9ta9
13 Nov 19
Report of Foriegn Private Issuer
5:18pm
6-K
EX-99.3
apkjd4fnta4kxfed
13 Nov 19
Report of Foriegn Private Issuer
5:18pm
424B4
ovhr4qe5 b8oes
28 Jun 19
Prospectus supplement with pricing info
3:51pm
F-1/A
i8sqz
26 Jun 19
Registration statement (foreign) (amended)
12:00am